14044 Federal Register / Vol. 79, No. 48 / Wednesday, March 12, 2014 / Notices 

The total annual burden hours 

estimated for this ICR are summarized 

in the table below. 

TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden hours 

Cost Tool ......................................................................................................... 30 1 8 240 

Implementation Tool ........................................................................................ 30 1 1 30 

Staff Time Use Survey .................................................................................... 600 2 20/60 400 

Economic Evaluation Form .............................................................................. 15 1 3 45 

Total .......................................................................................................... 715 

OS specifically requests comments on 

(1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions, (2) the accuracy of the 

estimated burden, (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Darius Taylor, 

Deputy, Information Collection Clearance 

Officer. 

[FR Doc. 2014–05286 Filed 3–11–14; 8:45 am] 

BILLING CODE 4150–30–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Meeting of the National Advisory 

Council for Healthcare Research and 

Quality 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ). 

ACTION: Notice of public meeting. 

SUMMARY: In accordance with section 

10(a) of the Federal Advisory Committee 

Act, 5 U.S.C. App. 2, this notice 

announces a meeting of the National 

Advisory Council for Healthcare 

Research and Quality. 

DATES: The meeting will be held on 

Friday, April 4, 2014, from 8:30 a.m. to 

3:30 p.m. 

ADDRESSES: The meeting will be held at 

the Eisenberg Conference Center, 

Agency for Healthcare Research and 

Quality, 540 Gaither Road, Rockville, 

Maryland 20850. 

FOR FURTHER INFORMATION CONTACT: 

Jaime Zimmerman, Designated 

Management Official, at the Agency for 

Healthcare Research and Quality, 540 

Gaither Road, Rockville, Maryland 

20850, (301) 427–1456. For press-related 

information, please contact Alison Hunt 

at (301) 427–1244. 

If sign language interpretation or other 

reasonable accommodation for a 

disability is needed, please contact the 

Food and Drug Administration (FDA) 

Office of Equal Employment 

Opportunity and Diversity Management 

on (301) 827–4840, no later than Friday, 

March 21, 2014. The agenda, roster, and 

minutes are available from Ms. Bonnie 

Campbell, Committee Management 

Officer, Agency for Healthcare Research 

and Quality, 540 Gaither Road, 

Rockville, Maryland 20850. Ms. 

Campbell’s phone number is (301) 427– 

1554. 

SUPPLEMENTARY INFORMATION: 

I. Purpose 

The National Advisory Council for 

Healthcare Research and Quality is 

authorized by Section 941 of the Public 

Health Service Act, 42 U.S.C. 299c. In 

accordance with its statutory mandate, 

the Council is to advise the Secretary of 

the Department of Health and Human 

Services and the Director, Agency for 

Healthcare Research and Quality 

(AHRQ), on matters related to AHRQ’s 

conduct of its mission including 

providing guidance on (A) priorities for 

health care research, (B) the field of 

health care research including training 

needs and information dissemination on 

health care quality and (C) the role of 

the Agency in light of private sector 

activity and opportunities for public 

private partnerships. 

The Council is composed of members 

of the public, appointed by the 

Secretary, and Federal ex-officio 

members specified in the authorizing 

legislation. 

II. Agenda 

On Friday, April 4, 2014, there will be 

a subcommittee meeting for the National 

Healthcare Quality and Disparities 

Report scheduled to begin at 7:30 a.m. 

The subcommittee meeting is open the 

public. The Council meeting will 

convene at 8:30 a.m., with the call to 

order by the Council Chair and approval 

of previous Council summary notes. The 

meeting is open to the public. The 

meeting will begin with the AHRQ 

Director presenting an update on 

current research, programs, and 

initiatives. Following the Director’s 

Update, the agenda will include an 

update from the subcommittee on 

Strategic Direction, an update on Health 

Insurance Coverage Expansion and a 

discussion on Delivery System Reform. 

The final agenda will be available on the 

AHRQ Web site at www.AHRQ.gov no 

later than Friday, March 28, 2014. 

Dated: February 26, 2014. 

Richard Kronick, 

AHRQ Director. 

[FR Doc. 2014–05353 Filed 3–11–14; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Solicitation for Nominations for 

Members of the U.S. Preventive 

Services Task Force (USPSTF) 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Solicits nominations for new 

members of USPSTF. 

SUMMARY: The Agency for Healthcare 

Research and Quality (AHRQ) invites 

nominations of individuals qualified to 

serve as members of the U.S. Preventive 

Services Task Force (USPSTF). 

DATES: All nominations submitted in 

writing or electronically will be 

considered for appointment to the 

USPSTF. Nominations must be received 

by May 15th of a given year to be 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 48 / Wednesday, March 12, 2014 / Notices 14045 

considered for appointment to begin in 

January of the following year. 

Arrangement for Public Inspection 

Nominations and applications are 

kept on file at the Center for Primary 

Care, Prevention, and Clinical 

Partnerships, AHRQ, and are available 

for review during business hours. AHRQ 

does not reply to individual 

nominations, but considers all 

nominations in selecting members. 

Information regarded as private and 

personal, such as a nominee’s social 

security number, home and email 

addresses, home telephone and fax 

numbers, or names of family members 

will not be disclosed to the public (in 

accord with the Freedom of Information 

Act, 5 U.S.C. 552(b)(6); 45 CFR 5.67). 

Nomination Submissions 

Nominations may be submitted in 

writing or electronically, but should 

include: 

1. The applicant’s current curriculum 

vitae and contact information, including 

mailing address, email address, and 

telephone number, and 

2. A letter explaining how this 

individual meets the qualification 

requirements and how he/she would 

contribute to the USPSTF. The letter 

should also attest to the nominee’s 

willingness to serve as a member of the 

USPSTF. 

AHRQ will later ask persons under 

serious consideration for USPSTF 

membership to provide detailed 

information that will permit evaluation 

of possible significant conflicts of 

interest. Such information will concern 

matters such as financial holdings, 

consultancies, and research grants or 

contracts. 

To obtain a diversity of perspectives, 

AHRQ particularly encourages 

nominations of women, members of 

minority populations, and persons with 

disabilities. Interested individuals can 

self-nominate. Organizations and 

individuals may nominate one or more 

persons qualified for membership on the 

USPSTF at any time. Individuals 

nominated prior to May 15, 2013, who 

continue to have interest in serving on 

the USPSTF, should be re-nominated. 

Qualification Requirements 

To qualify for the USPSTF and 

support its mission, an applicant or 

nominee should, at a minimum, 

demonstrate knowledge, expertise and 

national leadership in the following 

areas: 

1. The critical evaluation of research 

published in peer reviewed literature 

and in the methods of evidence review; 

2. Clinical prevention, health 

promotion and primary health care; and 

3. Implementation of evidence-based 

recommendations in clinical practice 

including at the clinician-patient level, 

practice level, and health system level. 

Additionally, the Task Force benefits 

from members with expertise in the 

following areas: 

D Public health 

D Health equity and the reduction of 

health disparities 

D Application of science to health 

policy 

D Communication of scientific 

findings to multiple audiences 

including health care professionals, 

policy makers and the general public. 

Candidates with experience and skills 

in any of these areas should highlight 

them in their nomination materials. 

Applicants must have no substantial 

conflicts of interest, whether financial, 

professional, or intellectual, that would 

impair the scientific integrity of the 

work of the USPSTF and must be 

willing to complete regular conflict of 

interest disclosures. 

Applicants must have the ability to 

work collaboratively with a team of 

diverse professionals who support the 

mission of the USPSTF. Applicants 

must have adequate time to contribute 

substantively to the work products of 

the USPSTF. 

ADDRESSES: Submit your responses 

either in writing or electronically to: 

Joya Chowdhury, ATTN: USPSTF 

Nominations, Center for Primary Care, 

Prevention, and Clinical Partnerships, 

Agency for Healthcare Research and 

Quality, 540 Gaither Road, Rockville, 

Maryland 20850, USPSTFmember

nominations@ahrq.hhs.gov. 

Nominee Selection 

Nominated individuals will be 

selected for the USPSTF on the basis of 

their qualifications (in particular, those 

that address the required qualifications, 

as outlined) and the current expertise 

needs of the USPSTF. It is anticipated 

that new members will be invited to 

serve on the USPSTF beginning in 

January, 2015. All nominated 

individuals will be considered; 

however, strongest consideration will be 

given to individuals with demonstrated 

training and expertise in the area of 

family medicine. AHRQ will retain and 

may consider nominations received this 

year and not selected during this cycle 

for future vacancies. 

Some USPSTF members without 

primary health care clinical experience 

may be selected based on their expertise 

in methodological issues such as metaanalysis, analytic modeling or clinical 

epidemiology. For individuals with 

clinical expertise in primary health care, 

additional qualifications in 

methodology would enhance their 

candidacy. 

FOR FURTHER INFORMATION CONTACT: Joya 

Chowdhury at USPSTFmember

nominations@ahrq.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

Under Title IX of the Public Health 

Service Act, AHRQ is charged with 

enhancing the quality, appropriateness, 

and effectiveness of health care services 

and access to such services 42 U.S.C. 

299(b). AHRQ accomplishes these goals 

through scientific research and 

promotion of improvements in clinical 

practice, including clinical prevention 

of diseases and other health conditions. 

See 42 U.S.C. 299(b). 

The USPSTF, an independent body of 

experts in prevention and evidencebased medicine, works to improve the 

health of all Americans by making 

evidence-based recommendations about 

the effectiveness of clinical preventive 

services and health promotion. The 

recommendations made by the USPSTF 

address clinical preventive services for 

adults and children, and include 

screening tests, counseling services, and 

preventive medications. 

The USPSTF was first established in 

1984 under the auspices of the U.S. 

Public Health Service. Currently, the 

USPSTF is convened by the Director of 

AHRQ, and AHRQ provides ongoing 

scientific, administrative, and 

dissemination support for the USPSTF’s 

operation. USPSTF members serve four 

year terms. New members are selected 

each year to replace those members who 

are completing their appointments. 

The USPSTF is charged with 

rigorously evaluating the effectiveness, 

appropriateness and cost-effectiveness 

of clinical preventive services and 

formulating or updating 

recommendations regarding the 

appropriate provision of preventive 

services. See 42 U.S.C. 299b–4(a)(1). 

Current USPSTF recommendations and 

associated evidence reviews are 

available on the Internet (www. 

uspreventiveservicestaskforce.org). 

USPSTF members currently meet 

three times a year for two days in the 

Washington, DC area. A significant 

portion of the USPSTF’s work occurs 

between meetings during conference 

calls and via email discussions. Member 

duties include prioritizing topics, 

designing research plans, reviewing and 

commenting on systematic evidence 

reviews of evidence, discussing and 

making recommendations on preventive 

services, reviewing stakeholder 


tkelley on DSK3SPTVN1PROD with NOTICES
14046 Federal Register / Vol. 79, No. 48 / Wednesday, March 12, 2014 / Notices 

comments, drafting final 

recommendation documents, and 

participating in workgroups on specific 

topics and methods. Members can 

expect to receive frequent emails, can 

expect to participate in multiple 

conference calls each month, and can 

expect to have periodic interaction with 

stakeholders. AHRQ estimates that 

members devote approximately 200 

hours a year outside of in-person 

meetings to their USPSTF duties. The 

members are all volunteers and do not 

receive any compensation beyond 

support for travel to in person meetings. 

Dated: February 26, 2014. 

Richard Kronick, 

AHRQ Director. 

[FR Doc. 2014–05354 Filed 3–11–14; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Scientific Information Request on 

Radiotherapy Treatments for Head and 

Neck Cancer 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Request for scientific 

information submissions. 

SUMMARY: The Agency for Healthcare 

Research and Quality (AHRQ) is seeking 

scientific information submissions from 

the public on 3-Dimensionsal Conformal 

Radiotherapy (3DRT), IntensityModulated Radiotherapy (IMRT), 

Stereotactic Body Radiotherapy (SBRT), 

and Proton Beam Radiotherapy (PBRT). 

Scientific information is being solicited 

to inform our update review of 

Radiotherapy Treatments for Head and 

Neck Cancer, which is currently being 

conducted by the Evidence-based 

Practice Centers for the AHRQ Effective 

Health Care Program. Access to 

published and unpublished pertinent 

scientific information on 3- 

Dimensionsal Conformal Radiotherapy 

(3DRT), Intensity-Modulated 

Radiotherapy (IMRT), Stereotactic Body 

Radiotherapy (SBRT), and Proton Beam 

Radiotherapy (PBRT) will improve the 

quality of this review. AHRQ is 

conducting this comparative 

effectiveness review pursuant to Section 

1013 of the Medicare Prescription Drug, 

Improvement, and Modernization Act of 

2003, Public Law 108–173, and Section 

902(a) of the Public Health Service Act, 

42 U.S.C. 299a(a). 

DATES: Submission Deadline on or 

before April 11, 2014. 

ADDRESSES: 

Online submissions: http:// 

effectivehealthcare.AHRQ.gov/ 

index.cfm/submit-scientificinformation-packets/. Please select the 

study for which you are submitting 

information from the list to upload your 

documents. 

Email submissions: SIPS@epc-src.org. 

Print submissions: 

Mailing Address: Portland VA 

Research Foundation, Scientific 

Resource Center, ATTN: Scientific 

Information Packet Coordinator, P.O. 

Box 69539, Portland, OR 97239. 

Shipping Address (FedEx, UPS, etc.): 

Portland VA Research Foundation, 

Scientific Resource Center, ATTN: 

Scientific Information Packet 

Coordinator, 3710 SW U.S. Veterans 

Hospital Road, Mail Code: R&D 71, 

Portland, OR 97239. 

FOR FURTHER INFORMATION CONTACT: 

Robin Paynter, Research Librarian, 

Telephone: 503–220–8262 ext. 58652 or 

Email: SIPS@epc-src.org. 

SUPPLEMENTARY INFORMATION: The 

Agency for Healthcare Research and 

Quality has commissioned the Effective 

Health Care (EHC) Program Evidencebased Practice Centers to complete an 

updated review of the evidence for 

Radiotherapy Treatments for Head and 

Neck Cancer. 

The EHC Program is dedicated to 

identifying as many studies as possible 

that are relevant to the questions for 

each of its reviews. In order to do so, we 

are supplementing the usual manual 

and electronic database searches of the 

literature by requesting information 

from the public (e.g., details of studies 

conducted). We are looking for studies 

that report on Radiotherapy Treatments 

for Head and Neck Cancer, including 

those that describe adverse events. The 

entire research protocol, including the 

key questions, is also available online 

at: http://effectivehealthcare.AHRQ.gov/ 

ehc/products/569/1852/head-neckcancer-update-140204.pdf. 

This notice is to notify the public that 

the EHC program would find the 

following information on 3- 

Dimensionsal Conformal Radiotherapy 

(3DRT), Intensity-Modulated 

Radiotherapy (IMRT), Stereotactic Body 

Radiotherapy (SBRT), and Proton Beam 

Radiotherapy (PBRT) helpful: 

• A list of completed studies your 

company has sponsored for this 

indication. In the list, indicate whether 

results are available on 

ClinicalTrials.gov along with the 

ClinicalTrials.gov trial number. 

• For completed studies that do not 

have results on ClinicalTrials.gov, a 

summary, including the following 

elements: study number, study period, 

design, methodology, indication and 

diagnosis, proper use instructions, 

inclusion and exclusion criteria, 

primary and secondary outcomes, 

baseline characteristics, number of 

patients screened/eligible/enrolled/lost 

to follow-up/withdrawn/analyzed, 

effectiveness/efficacy, and safety results. 

• A list of ongoing studies your 

company has sponsored for this 

indication. In the list, please provide the 

ClinicalTrials.gov trial number or, if the 

trial is not registered, the protocol for 

the study including a study number, the 

study period, design, methodology, 

indication and diagnosis, proper use 

instructions, inclusion and exclusion 

criteria, and primary and secondary 

outcomes. 

• Description of whether the above 

studies constitute ALL Phase II and 

above clinical trials sponsored by your 

company for this indication and an 

index outlining the relevant information 

in each submitted file. 

Your contribution is very beneficial to 

the Program. The contents of all 

submissions will be made available to 

the public upon request. Materials 

submitted must be publicly available or 

can be made public. Materials that are 

considered confidential; marketing 

materials; study types not included in 

the review; or information on 

indications not included in the review 

cannot be used by the Effective Health 

Care Program. This is a voluntary 

request for information, and all costs for 

complying with this request must be 

borne by the submitter. 

The draft of this review will be posted 

on AHRQ’s EHC program Web site and 

available for public comment for a 

period of 4 weeks. If you would like to 

be notified when the draft is posted, 

please sign up for the email list at: 

http://effectivehealthcare.AHRQ.gov/ 

index.cfm/join-the-email-list1/. 

The systematic review will answer the 

following questions. This information is 

provided as background. AHRQ is not 

requesting that the public provide 

answers to these questions. The entire 

research protocol, is also available 

online at: http:// 

effectivehealthcare.AHRQ.gov/ehc/ 

products/569/1852/head-neck-cancerupdate-140204.pdf 

Key Questions (KQs) 

Key Question 1 

What is the comparative effectiveness 

of 3DRT, IMRT, SBRT, and PBRT 

regarding adverse events and quality of 

life (QoL)? 


tkelley on DSK3SPTVN1PROD with NOTICES